Interim data from an ongoing open-label extension study support the long-term safety and efficacy of atogepant for prevention ...

NHS officials have endorsed Atogepant, a medication poised to alleviate the suffering of numerous individuals afflicted by ...

When you're in pain from a migraine headache, you need relief. The medical professionals at Physical Medicine are here to ...

NHS spending watchdog NICE has recommended a once-daily pill to treat migraines on the health service in Wales and England | ...

In the first randomized controlled trial, vaporized cannabis containing a THC-CBD mix led to rapid and sustained relief of ...

A third of the nearly 20 million women who participated in a national health survey report migraines during menstruation, and ...

Among U.S. women with migraine, a third say the attacks tend to coincide with their periods, a new survey finds.

AbbVie’s small molecule drug Qulipta has durable benefits and can reduce migraine frequency through 48 weeks of follow-up, ...

In a primary analysis of the Harris Poll Migraine Report Card survey, researchers compared self-reported experiences of adults with HFM+AMO vs those who previously experienced HFM+AMO but currently ...

Atogepant has been given the green light for NHS use in England by the National Institute for Health and Care Excellence. | ...

While there was a breakthrough for the treatment of migraines yesterday, the journey to find a cure has been long, but while there is still no ‘magic bullet’ the news will still have a dramatic impact ...

A third of the nearly 20 million women who participated in a national health survey reports migraines during menstruation, and of them, 11.8 million, or 52.5%, were premenopausal.